Where I see patients (6)
Adverse Consequences of Chronic Kidney Disease on Bone Health in Children.
Seminars in nephrology
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension.
Renal Dnase1 expression is regulated by FGF23 but loss of Dnase1 does not alter renal phosphate handling.
Tender wagging care